Leerink Partnrs Has Optimistic Outlook of THC Q3 Earnings

Tenet Healthcare Co. (NYSE:THC) – Research analysts at Leerink Partnrs lifted their Q3 2025 earnings per share (EPS) estimates for Tenet Healthcare in a report issued on Tuesday, June 3rd. Leerink Partnrs analyst W. Mayo now anticipates that the company will post earnings per share of $2.28 for the quarter, up from their previous forecast of $2.17. The consensus estimate for Tenet Healthcare’s current full-year earnings is $12.24 per share. Leerink Partnrs also issued estimates for Tenet Healthcare’s Q4 2025 earnings at $3.02 EPS, Q3 2026 earnings at $2.91 EPS, Q4 2026 earnings at $3.69 EPS, FY2026 earnings at $13.98 EPS and FY2027 earnings at $17.19 EPS.

Tenet Healthcare (NYSE:THC) last released its quarterly earnings results on Tuesday, April 29th. The company reported $4.36 EPS for the quarter, topping the consensus estimate of $3.11 by $1.25. The business had revenue of $5.22 billion during the quarter, compared to analyst estimates of $5.15 billion. Tenet Healthcare had a return on equity of 21.88% and a net margin of 15.48%. The company’s quarterly revenue was down 2.5% on a year-over-year basis. During the same period last year, the business posted $3.22 earnings per share.

THC has been the topic of several other reports. Wells Fargo & Company upgraded Tenet Healthcare from an “equal weight” rating to an “overweight” rating and increased their price objective for the company from $150.00 to $195.00 in a research note on Thursday, May 29th. Baird R W cut Tenet Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, April 15th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $177.00 price objective on shares of Tenet Healthcare in a research note on Thursday, February 13th. Robert W. Baird restated a “neutral” rating and issued a $137.00 price target (down from $153.00) on shares of Tenet Healthcare in a research note on Tuesday, April 15th. Finally, Guggenheim began coverage on Tenet Healthcare in a research note on Wednesday, April 9th. They issued a “buy” rating and a $165.00 price target on the stock. Four equities research analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, Tenet Healthcare currently has an average rating of “Moderate Buy” and a consensus target price of $180.18.

Tenet Healthcare Stock Down 0.3%

Shares of NYSE THC opened at $171.36 on Friday. The stock has a market cap of $15.92 billion, a P/E ratio of 5.32, a PEG ratio of 1.02 and a beta of 1.65. The company has a current ratio of 1.78, a quick ratio of 1.70 and a debt-to-equity ratio of 2.25. Tenet Healthcare has a 12-month low of $109.82 and a 12-month high of $174.14. The business’s fifty day simple moving average is $144.43 and its 200-day simple moving average is $136.98.

Hedge Funds Weigh In On Tenet Healthcare

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. Strs Ohio purchased a new position in shares of Tenet Healthcare during the first quarter worth about $1,550,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in Tenet Healthcare by 4.9% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 276,969 shares of the company’s stock valued at $37,252,000 after purchasing an additional 12,914 shares in the last quarter. Empowered Funds LLC boosted its holdings in Tenet Healthcare by 19.6% in the 1st quarter. Empowered Funds LLC now owns 154,754 shares of the company’s stock valued at $20,814,000 after purchasing an additional 25,323 shares in the last quarter. United Services Automobile Association purchased a new stake in Tenet Healthcare in the 1st quarter valued at approximately $821,000. Finally, Fred Alger Management LLC purchased a new stake in Tenet Healthcare in the 1st quarter valued at approximately $2,652,000. Hedge funds and other institutional investors own 95.44% of the company’s stock.

Insider Transactions at Tenet Healthcare

In related news, EVP Paola M. Arbour sold 7,738 shares of the firm’s stock in a transaction dated Thursday, June 5th. The stock was sold at an average price of $173.00, for a total transaction of $1,338,674.00. Following the transaction, the executive vice president now owns 20,110 shares of the company’s stock, valued at $3,479,030. This trade represents a 27.79% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, Director Richard W. Fisher sold 836 shares of the firm’s stock in a transaction dated Thursday, June 5th. The stock was sold at an average price of $173.16, for a total value of $144,761.76. Following the transaction, the director now directly owns 11,292 shares in the company, valued at approximately $1,955,322.72. This represents a 6.89% decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 63,646 shares of company stock worth $10,041,025. Corporate insiders own 0.81% of the company’s stock.

About Tenet Healthcare

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.